Tag: weight loss drugs
-
Uncommon Knowledge: Trump’s Obesity Fix — SNAP Bans and Subsidized Drugs
Overview: A bold approach to obesity policy In recent policy circles, the term “obesity fix” has been associated with a mix of regulatory tightening and targeted subsidies. Proponents argue that aligning federal assistance programs with contemporary medical options could reduce obesity rates and related health costs. Critics fear such measures may overstep economic and civil…
-
Trump Administration Reaches Deals to Lower GLP-1 Weight Loss Drug Prices for Medicare Patients
The Trump administration announced a set of price-lowering agreements on Thursday with two of the world’s leading pharmaceutical companies, Novo Nordisk and Eli Lilly. The deals target GLP-1 receptor agonists—drugs widely prescribed for weight management and diabetes—that have faced scrutiny for their rising costs in recent years. By negotiating rebates and price caps, officials say…
-
Ozempic Sober: What GLP-1 Medications Could Mean for Alcohol Intoxication
What “Ozempic sober” means Recent research has sparked discussion about a possible new effect of GLP-1 receptor agonists, a class of drugs that includes Ozempic (semaglutide). The term “Ozempic sober” has surfaced in media coverage to describe a potential change in how the body processes and experiences alcohol while on these medications. Early signals from…
-
Unusual PET-CT Scan Patterns Linked to GLP-1 Weight-Loss Drugs
Overview: A new imaging wrinkle around popular GLP-1 medications GLP-1 receptor agonists, a class of drugs that has surged in popularity for weight loss and type 2 diabetes management, are facing fresh scrutiny. While these medications—sold under names like Ozempic, Wegovy, and Mounjaro—continue to help many shed pounds, doctors are now noting unfamiliar patterns on…
-
Ketone Supplement May Shield Muscle From Weight-Loss Drug Side Effects
New findings suggest a simple supplement could safeguard lean mass during weight-loss drug therapy A University of Alberta study points to a promising way to mitigate a tricky consequence of popular weight-loss medications: the loss of lean muscle and even heart muscle when using semaglutide-based treatments such as Ozempic, Wegovy, and Rybelsus. Researchers explored whether…
-
Ketone Supplement May Protect Muscle in Weight-Loss Drug Therapy
New approach to safer weight-loss drug therapy A recent study from the University of Alberta suggests that a simple ketone-based supplement could help protect lean muscle while patients shed fat on popular weight-loss drugs like semaglutide. The research, described as a way to “fine-tune” the therapy, indicates that ketones may preserve skeletal and cardiac muscle…